Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Centessa Pharmaceuticals PLC
Interest Income Expense
Centessa Pharmaceuticals PLC
Interest Income Expense Peer Comparison
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
Interest Income Expense
$570k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Exscientia PLC
NASDAQ:EXAI
|
Interest Income Expense
£12.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
Interest Income Expense
-$29m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
Interest Income Expense
$13.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
125%
|
CAGR 10-Years
N/A
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
Interest Income Expense
-£344k
|
CAGR 3-Years
21%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Genus PLC
LSE:GNS
|
Interest Income Expense
-£10.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-102%
|
CAGR 10-Years
-20%
|
See Also
What is Centessa Pharmaceuticals PLC's Interest Income Expense?
Interest Income Expense
570k
USD
Based on the financial report for Dec 31, 2023, Centessa Pharmaceuticals PLC's Interest Income Expense amounts to 570k USD.